Company Analysis

VivoSim Labs, Inc. (VIVS)

Nasdaq: VIVS · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2010
Grade3.3
◀ Past 1.7● Present 2.7▶ Future 4.8
1 est.

Who runs VivoSim Labs, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
29 people on the record since 2012
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Lialin Tony SergeChief Commercial OfficerAug 2025Sep 1, 2026none
Murphy KeithEXECUTIVE CHAIRMANMar 2012Jan 29, 2026none
Sethi Amar AkhtarChief Scientific OfficerNov 2025Nov 26, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Cohen Douglas JaydirectorSep 2020Jan 29, 2026none
Gobel DaviddirectorSep 2020Jan 29, 20261 · $0.00
Milhous Alison TjosvolddirectorSep 2020Jan 29, 2026none
Stern Adam KdirectorMar 2012Jan 29, 2026none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton VIVS · research, not advice